Table 2.
SIRT1 |
MMP2 |
FOXO3a |
||||
---|---|---|---|---|---|---|
r | P-value | r | P-value | r | P-value | |
Age | −0.39 | 0.05 | −0.77 | <0.001 | -05 | 0.01 |
Grade | 0.55 | 0.005 | 0.12 | 0.57 | 0.005 | 0.98 |
Stage | 0.48 | 0.02 | 0.52 | 0.01 | 0.435 | 0.03 |
Tumor size | 0.36 | 0.08 | 0.03 | 0.87 | 0.103 | 0.63 |
CA15.3 | −0.44 | 0.03 | −0.4 | 0.05 | -0.6 | 0.002 |
CEA | −0.34 | 0.10 | −0.45 | 0.02 | −0.65 | 0.001 |
Lymph node | 0.67 | <0.001 | 0.71 | <0.001 | 0.51 | 0.01 |
SIRT1 | – | – | 0.75 | <0.001 | 0.8 | <0.001 |
MMP2 | 0.75 | <0.001 | – | – | 0.7 | <0.001 |
FOXO3a | 0.8 | <0.001 | 0.7 | <0.001 | – | – |
CA: cancer antigen, CEA: carcinoembryonic antigen, SIRT1: sirtuin 1, MMP2: matrix metalloproteinases, FOXO3a: forkhead box O3a. Significance was considered at P < 0.05.